tiprankstipranks
Trending News
More News >
Ajanta Pharma Limited (IN:AJANTPHARM)
:AJANTPHARM
India Market

Ajanta Pharma Limited (AJANTPHARM) Financial Statements

Compare
4 Followers

Ajanta Pharma Limited Financial Overview

Ajanta Pharma Limited's market cap is currently ₹345.78B. The company's EPS TTM is ₹20.8; its P/E ratio is 35.51; and it has a dividend yield of 1.04%. Ajanta Pharma Limited is scheduled to report earnings on November 3, 2025, and the estimated EPS forecast is ₹19.34. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue₹ 46.48B₹ 42.09B₹ 37.43B₹ 32.84B₹ 28.47B
Gross Profit₹ 35.77B₹ 30.93B₹ 26.32B₹ 23.97B₹ 21.65B
Operating Income₹ 22.64B₹ 19.68B₹ 7.11B₹ 7.82B₹ 8.64B
EBITDA₹ 12.68B₹ 12.57B₹ 8.81B₹ 10.44B₹ 10.24B
Net Income₹ 9.20B₹ 8.16B₹ 5.88B₹ 7.13B₹ 6.54B
Balance Sheet
Cash & Short-Term Investments₹ 6.15B₹ 4.60B₹ 8.44B₹ 3.28B₹ 3.78B
Total Assets₹ 50.15B₹ 46.38B₹ 46.79B₹ 40.56B₹ 37.79B
Total Debt₹ 474.20M₹ 352.80M₹ 356.30M₹ 250.30M₹ 313.60M
Net Debt₹ -1.29B₹ -942.10M₹ -2.94B₹ -1.81B₹ -1.46B
Total Liabilities₹ 12.25B₹ 10.71B₹ 12.91B₹ 7.91B₹ 7.83B
Stockholders' Equity₹ 37.90B₹ 35.67B₹ 33.88B₹ 32.64B₹ 29.96B
Cash Flow
Free Cash Flow₹ 8.39B₹ 6.33B₹ 6.17B₹ 4.13B₹ 4.05B
Operating Cash Flow₹ 11.57B₹ 7.85B₹ 7.92B₹ 5.62B₹ 5.76B
Investing Cash Flow₹ -3.77B₹ 653.90M₹ -5.60B₹ -741.00M₹ -2.82B
Financing Cash Flow₹ -7.33B₹ -10.51B₹ -1.08B₹ -4.60B₹ -3.18B
Currency in INR

Ajanta Pharma Limited Earnings and Revenue History

Ajanta Pharma Limited Debt to Assets

Ajanta Pharma Limited Cash Flow

Ajanta Pharma Limited Forecast EPS vs Actual EPS